摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-[(2-Ethoxyphenyl)-(4-methylpiperazin-1-yl)methyl]-3-methyl-1,2-thiazole | 90671-11-7

中文名称
——
中文别名
——
英文名称
5-[(2-Ethoxyphenyl)-(4-methylpiperazin-1-yl)methyl]-3-methyl-1,2-thiazole
英文别名
——
5-[(2-Ethoxyphenyl)-(4-methylpiperazin-1-yl)methyl]-3-methyl-1,2-thiazole化学式
CAS
90671-11-7
化学式
C18H25N3OS
mdl
——
分子量
331.482
InChiKey
YTRUYFONPISSBQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    23
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    56.8
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    2-乙氧基苯甲醛 在 sodium metabisulfite 、 正丁基锂氯化亚砜 、 sodium carbonate 作用下, 以 甲苯 为溶剂, 反应 16.5h, 生成 5-[(2-Ethoxyphenyl)-(4-methylpiperazin-1-yl)methyl]-3-methyl-1,2-thiazole
    参考文献:
    名称:
    Heterocyclic analogs of chlorcyclizine with potent hypolipidemic activity
    摘要:
    A series of [alpha-(heterocyclyl)benzyl]piperazines was synthesized and their effect of reducing serum cholesterol and triglyceride levels in the rat was evaluated. A systematic exploration of the structure-activity relationships led to the synthesis of (R,S)-(3,5-dimethylisoxazol-4-yl)[4-(1-methylethyl)phenyl] (4-methylpiperazin-1-yl)methane dihydrochloride (M&B 31 426), which had potent activity in lowering serum lipid levels at a daily oral dose of 2 mg/kg and was 100 times more potent than clofibrate.
    DOI:
    10.1021/jm00376a002
点击查看最新优质反应信息

文献信息

  • Heterocyclic analogs of chlorcyclizine with potent hypolipidemic activity
    作者:Michael J. Ashton、Alan Ashford、Anthony H. Loveless、David Riddell、John Salmon、Gregory V. W. Stevenson
    DOI:10.1021/jm00376a002
    日期:1984.10
    A series of [alpha-(heterocyclyl)benzyl]piperazines was synthesized and their effect of reducing serum cholesterol and triglyceride levels in the rat was evaluated. A systematic exploration of the structure-activity relationships led to the synthesis of (R,S)-(3,5-dimethylisoxazol-4-yl)[4-(1-methylethyl)phenyl] (4-methylpiperazin-1-yl)methane dihydrochloride (M&B 31 426), which had potent activity in lowering serum lipid levels at a daily oral dose of 2 mg/kg and was 100 times more potent than clofibrate.
查看更多